Skip to main content
. 2021 Aug 7;9(8):976. doi: 10.3390/biomedicines9080976

Figure 8.

Figure 8

The combined treatment of hydralazine and enzalutamide downregulated the invasion potential of PCa (prostate cancer) cell lines. Values were normalized to the vehicle condition. (V—vehicle, H—hydralazine, E—enzalutamide, H+E—combination of hydralazine and enzalutamide).